Lifecore Biomedical agrees to Webster Equity Partners buyout, extends Alcon manufacturing deal to 2034
The deal, valued at up to $663.7 million with milestone payments, follows a September 24 amendment that extends Lifecore's contract manufacturing agreement with Alcon Research through 2034.
SEC filing (2)